Medicines Formulary

Reports

Drug name	NICE TAs	Comments
Citalopram oral drops		Not recommended routinely due to QT ptolongation risk
Citalopram tablets		Not recommended routinely due to QT ptolongation risk
Clindamycin (Dalacin®) 2% cream
Clindamycin 1% topical solution
Clinitas®		Non bak
Clobetasone butyrate 0.05% cream	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Moderate potency
Clobetasone butyrate 0.05% ointment	TA85 - Frequency of application of topical corticosteroids for atopic eczema	Moderate potency
Clomipramine capsules		Specialist initiation only
Clopidogrel 75mg tablets	TA80 - Clopidogrel in the treatment of non-ST-segment-elevation acute coronary syndrome TA210 - Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events
Clotrimazole - all formulations

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
Next page
Last page

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.